Progressive supranuclear palsy

doi:10.1017/CBO9780511544873.045

44 - Progressive supranuclear palsy

from Part VII - Parkinson's and related movement disorders

Published online by Cambridge University Press: 04 August 2010

Anthony E. Lang and

M. Flint Beal: Affiliation:
Cornell University, New York
Anthony E. Lang: Affiliation:
University of Toronto
Albert C. Ludolph: Affiliation:
Universität Ulm, Germany
Lawrence I. Golbe: Affiliation:
Department of Neurology, Robert Wood Johnson Medical School, New Brunswick, NJ, USA

Book contents

Get access

Summary

Introduction

Progressive supranuclear palsy (PSP) is unusual among the neurodegenerative disorders in the variety of neural structures it involves and the complexity of the illness that results. The tau-based neurofibrillary tangles and the associated degeneration affect both neurons and glia. The damage involves systems at every level from cerebral cortex to lumbar spinal cord. It affects dopaminergic, cholinergic and GABAergic systems. Its superficial clinical resemblance to Parkinson's disease (PD) and close pathological resemblance to postencephalitic parkinsonism delayed its definitive clinicopathological description until the early 1960s. (Richardson, 1963; Olszewski, 1963; Steele et al., 1964). Its full-blown, typical clinical appearance is unmistakable, but atypical forms are frequent and multiple conditions can mimic it.

The etiology of PSP is no clearer than that of most other neurodegenerative disorders but the late 1990s have brought important new insights into the molecular defects underlying neurofibrillary tangle formation. Such insights will probably prove the best route to treatment of PSP, as symptomatic palliative treatments have been disappointing.

Clinical summary

Presentation

In its full-blown, typical state, PSP will not be confused with other illnesses. There can be little diagnostic doubt in a patient with a progressive syndrome of gait instability with early falls, neck rigidity with erect posture and bradykinesia, predominantly vertical supranuclear gaze abnormality, spastic dysarthria, dangerous dysphagia, tonically contracted facies and frontal behavioral abnormalities.

Restriction of vertical gaze with preserved oculocephalic reflexes is the most specific feature of PSP and the source of its name.

Type: Chapter
Information: Neurodegenerative Diseases
Neurobiology, Pathogenesis and Therapeutics
, pp. 663 - 681

DOI: https://doi.org/10.1017/CBO9780511544873.045 [Opens in a new window]

Publisher: Cambridge University Press

Print publication year: 2005

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Book purchase

Temporarily unavailable

References

Abe, K., Terakawa, H., Takanashi, M.et al. (2000). Proton magnetic resonance spectroscopy of patients with parkinsonism. Brain Res. Bull., 52, 589–95CrossRef Google Scholar PubMed

Agid, Y., Javoy-Agid, F., Ruberg, M.et al. (1987). PSP: anatomo-clinical and biochemical considerations. Adv. Neurol., 45, 191–206Google Scholar

Albers, D. S., Augood, S. J., Martin, D. M., Standaert, D. G., Vonsattel, J. P. G. & Beal, M. F. (1999). Evidence for oxidative stress in the subthalamic nucleus in PSP. J. Neurochem., 73, 881–4CrossRef Google Scholar

Aldrich, M. S., Foster, N. L., White, R. F.. & Prokopowicz, G. (1989). Sleep abnormalities in PSP. Ann. Neurol., 25, 577–81CrossRef Google Scholar

Anouti, A., Schmidt, K., Lyons, K. E.et al. (1996). Normal distribution of apolipoprotein E alleles in PSP. Neurology, 46, 1156–7CrossRef Google Scholar

Arai, N. (1987). “Grumose degeneration” of the dentate nucleus: a light and electron microscopic study in PSP and dentatorubropallidoluysian atrophy. J. Neurol. Sci., 90, 131–45CrossRef Google Scholar

Averbuch-Heller, L., Paulson, G. W., Daroff, R. B. & Leigh, R. J. (1999). Whipple's disease mimicking PSP: the diagnostic value of eye movement recording. J. Neurol. Neurosurg. Psychiatr., 66, 532–5CrossRef Google Scholar

Baker, K. B. & Montgomery, E. B. Jr. (2001). Performance on the PD test battery by relatives of patients with PSP. Neurology, 56, 25–30CrossRef Google Scholar

Baker, M., Litvan, I., Houlden, H.et al. (1999). Association of an extended haplotype in the tau gene with PSP. Hum. Mol. Genet., 8, 711–15CrossRef Google Scholar

Baron, J. C., Mazière, B., Loc'h, C.et al. (1986). Loss of striatal (76Br)-bromospiperone binding sites demonstrated by positron emission tomography in PSP. J. Cereb. Blood. Flow. Metab., 6, 131–6CrossRef Google Scholar

Bergeron, C., Pollanen, M. S., Weyer, L. & Lang, A. E. (1997). Cortical degeneration in PSP: a comparison with cortical-basal ganglionic degeneration. J. Neuropath. Exp. Neurol., 56, 726–34CrossRef Google Scholar PubMed

Bertoni, J. N., Label, L. S., Sackellares, C. & Hicks, S. P. (1983). Supranuclear gaze palsy in familial Creutzfeldt–Jakob disease. Arch. Neurol., 40, 618–22CrossRef Google Scholar PubMed

Birdi, S., Rajput, A. H., Fenton, M.et al. (2002). PSP diagnosis and confounding features: report on 16 autopsied cases. Mov. Disord., 17, 1255–67CrossRef Google Scholar PubMed

Bower, J. H., Maraganore, D. M., McDonnell, S. K. & Rocca, W. A. (1997). Incdence of PSP and multiple system atrophy in Olmsted County, Minnesota, 1976 to 1990. Neurology, 49, 1284–8CrossRef Google Scholar

Braak, H., Jellinger, K., Braak, E. & Bohl, J. (1992). Allocortical neurofibrillary changes in PSP. Acta Neuropath., 84, 478–83CrossRef Google Scholar

Brooks, D. J., Ibanez, V., Sawle, G. V.et al. (1990). Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and PSP. Ann. Neurol., 28, 547–55CrossRef Google Scholar

Brooks, D. J., Ibanez, V., Sawle, G. V.et al. (1992). Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and PSP, measured with 11C-raclopride and positron emission tomography. Ann. Neurol., 31, 184–92CrossRef Google Scholar PubMed

Brown, J., Lantos, P., Stratton, M., Roques, P. & Rossor, M. (1993). Familial PSP. J. Neurol. Neurosurg. Psychiatr., 56, 473–6CrossRef Google Scholar

Brown, P., Gibbs, C. J., Rodgers-Johnson, P.et al. (1994). Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann. Neurol., 35, 513–29CrossRef Google Scholar PubMed

Bueé-Scherrer, V., Bueé, L., Hof, P. R.et al. (1995). Neurofibrillary degeneration in amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam. Immunochemical characterisation of tau proteins. Am. J. Pathol., 146, 924–32Google Scholar

Burn, D. J., Sawle, G. V. & Brooks, D. J. (1994). Differential diagnosis of Parkinson's disease, multiple system atrophy, and Steele–Richardson–Olszewski syndrome: discriminant analysis of striatal 18F-dopa PET data. J. Neurol. Neurosurg. Psychiatr., 57, 278–84CrossRef Google Scholar PubMed

Cantuti-Castelvetri, I., Keller-McGandy, C. E. & Albers, D. S.et al. (2002). Expression and activity of antioxidants in the brain in PSP. Brain Res., 15, 170–81CrossRef Google Scholar

Caparros-Lefebvre, D., Elbaz, A. and the Caribbean Parkinsonism Study Group (1999). Possible relation of atypical parkinsonism in the French West Indies with consumption of tropical plants: a case-control study. Lancet, 354, 281–6CrossRef Google Scholar PubMed

Caparros-Lefebvre, D., Sergeant, N., Lees, A.et al. (2002). Guadeloupean parkinsonism: a cluster of PSP-like tauopathy. Brain, 125, 801–11CrossRef Google Scholar

Carpenter, M. B., Harbison, J. W. & Peter, P. (1970). Accessory oculomotor nuclei in the monkey: projections and effects of discrete lesions. J. Comp. Neurol., 140, 131–47CrossRef Google Scholar PubMed

Chirichigno, J., Manfredi, G., Beal, M.. (2002). Stress-induced mitochondrial depolarization and oxidative damage in PSP hybrids. Brain Res., 95, 31–35CrossRef Google Scholar

Chu, F. C., Reingold, D. B., Cogan, D. G. & Williams, A. C. (1979). The eye movement disorders of PSP. Ophthalmology, 86, 422–8CrossRef Google Scholar

Clarke, C. E. & Lowry, M. (2001). Systematic review of proton magnetic resonance spectroscopy of the striatum in parkinsonian syndromes. Eur. J. Neurol., 8, 573–7CrossRef Google Scholar PubMed

Collins, S. J., Ahlskog, J. E., Parisi, J. E. & Maraganore, D. M. (1995). PSP: neuropathologically based diagnostic clinical criteria. J. Neurol. Neurosurg. Psychiatr., 58, 167–73CrossRef Google Scholar PubMed

Colosimo, C., Albanese, A., Hughes, A. J., Bruin, V. M. & Lees, A. J. (1995). Some specific clinical features differentiate multiple system atrophy (striatonigral variety) from Parkinson's disease. Arch. Neurol., 52, 294–8CrossRef Google Scholar PubMed

Conrad, C., Andreadis, A., Trojanowski, J. Q.et al. (1997). Genetic evidence for the involvement of tau in PSP. Ann. Neurol., 41, 277–81CrossRef Google Scholar

Cordato, N. J., Halliday, G. M., Harding, A. J., Hely, M. A. & Morris, J. G. L. (2000). Regional brain atrophy in PSP and Lewy body disease. Ann. Neurol., 47, 718–283.0.CO;2-J>CrossRef Google Scholar PubMed

Curran, T. & Lang, A. E. (1994). Parkinsonian syndromes associated with hydrocephalus: case reports, a review of the literature, and pathophysiological hypotheses. Mov. Disord., 9, 508–20CrossRef Google Scholar PubMed

D'Antona, R., Baron, J. C., Sanson, Y.et al. (1985). Subcortical dementia: Frontal cortex hypometabolism detected by positron tomography in patients with PSP. Brain, 108, 785–99CrossRef Google Scholar

Davie, C. A., Barker, G. J., Machado, C., Miller, D. H. & Lees, A. J. (1997). Proton magnetic resonance spectroscopy in Steele–Richardson–Olszewski syndrome. Movement Disord., 12, 767–71CrossRef Google Scholar PubMed

Davis, P. H., Bergeron, C. & McLachlan, D. R. (1985). Atypical presentation of PSP. Ann. Neurol., 17, 337–43CrossRef Google Scholar

Davis, P. H., Golbe, L. I., Duvoisin, R. C. & Schoenberg, B. S. (1988). Risk factors for PSP. Neurology, 38, 1546–52CrossRef Google Scholar

Silva, R., Weiler, M., Morris, H. R., Martin, E. R., Wood, N. W. & Lees, A. J. (2001). Strong association of a novel tau promoter haplotype in PSP. Neurosci. Lett., 311, 145–8CrossRef Google Scholar

Yébenes, J. G., Sarasa, J. L., Daniel, S. E. & Lees, A. J. (1995). Familial PSP. Description of a pedigree and review of the literature. Brain, 118, 1093–103Google Scholar PubMed

Dehaene, I. (1984). Apraxia of eyelid opiening in PSP. Neurology, 15, 115–16Google Scholar

Di Maria, E., Tabaton, M., Vigo, T.et al. (2000). Corticobasal degeneration shares a common genetic background with PSP. Ann. Neurol., 47, 374–73.0.CO;2-8>CrossRef Google Scholar

Di Monte, C. A., Harati, Y., Jankovic, J., Sandy, M. S., Jewell, S. A. & Langston, J. W. (1994). Muscle mitochondrial ATP production in PSP. J. Neurochem., 62, 1631–4CrossRef Google Scholar

Dickson, D. W. (1997). Neurodegenerative diseases with cytoskeletal pathology: a biochemical classification. Ann. Neurol., 42, 541–4CrossRef Google Scholar PubMed

Drayer, B. P., Olanow, W., Burger, P., Johnson, G. A., Herfkens, R. & Riederer, S. (1986). Parkinson plus syndrome: diagnosis using high field MR imaging of brain iron. Radiology, 159, 493–8CrossRef Google Scholar

Dubas, F., Gray, F. & Escourolle, R. (1992). Maladie de Steele–Richardson–Olszewski sans ophthalmoplégie; 6 cas anatomo-cliniques. Rev. Neurol., 139, 407–16Google Scholar

Dubinsky, R. M. & Jankovic, J. (1987). PSP and a multi-infarct state. Neurology, 37, 570–6CrossRef Google Scholar

Dubois, B., Slachevsky, A., Litvan, I. & Pillon, B. (2000). The FAB: a Frontal Assessment Battery at bedside. Neurology, 55, 1621–6CrossRef Google Scholar PubMed

Elipe, J. G., Sanchez Pernaute, R., Sandiumenge, A. & Yebenes, J. G. (1996). Clinical symptoms in relatives of probands with PSP. Neurology, 46, A386–7Google Scholar

Ezquerra, M., Pastor, P., Valldeoriola, F.et al. (1999). Identification of a novel polymorphism in the promoter region of the tau gene highly associated to PSP in humans. Neurosci. Lett., 275, 183–6CrossRef Google Scholar PubMed

Fearnley, J. M. & Lees, A. J. (1991). Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain, 114, 2283–301CrossRef Google Scholar PubMed

Fearnley, J. M., Revesz, T., Brooks, D. J., Frackowiak, R. S. J. & Lees, A. J. (1991). Diffuse Lewy body disease presenting with a supranuclear gaze palsy. J. Neurol. Neurosurg. Psychiatr., 54, 159–61CrossRef Google Scholar PubMed

Flament, S., Delacourte, A., Verny, M., Hauw, J.-J. & Javoy-Agid, F. (1991). Abnormal tau proteins in PSP. Acta Neuropathol. (Berl.), 81, 591–6CrossRef Google Scholar

Foster, N. L., Gilman, S., Berent, S., Morin, E. M., Brown, M. B. & Koeppe, R. A. (1988). Cerebral hypometabolism in PSP studied with positron emission tomography. Ann. Neurol., 24, 399–406CrossRef Google Scholar PubMed

Fukushima-Kudo, J., Fukushima, K. & Tahiro, K. (1987). Rigidity and dorsiflexion of the neck in PSP and the interstitial nucleus of Cajal. J. Neurol. Neurosurg. Psychiatr., 50, 1197–203CrossRef Google Scholar

Gazely, S. & Maguire, J. (1994). Familial PSP. Brain Pathol, 4, 534Google Scholar

Gearing, M., Olson, D. A., Watts, R. L. & Mirra, S. S. (1994). PSP: neuropathologic and clinical heterogeneity. Neurology, 44, 1015–24CrossRef Google Scholar PubMed

Gert van Dijk, J., Haan, J., Koenderink, M. & Roos, R. A. C. (1991). Autonomic nervous function of PSP. Arch. Neurol., 48, 1083–4CrossRef Google Scholar

Ghatak, N. R., Nochlin, D. & Hadfield, M. G. (1980). Neurofibrillary pathology in PSP. Acta Neuropathol. (Berl.), 52, 73–6CrossRef Google Scholar

Giaccone, G., Tagliavini, F., Street, J. S., Ghetti, B. & Bugiani, O. (1988). PSP with hypertrophy of the olives: an immunohistochemical study of argyrophilic neurons. Acta Neuropathol. (Berl.), 77, 14–20CrossRef Google Scholar

Gibb, W. R. G., Luthert, P. J. & Marsden, C. D. (1989). Corticobasal degeneration. Brain, 112, 1171–92CrossRef Google Scholar PubMed

Goffinet, A. M., Volder, A. G., Guillain, C.et al. (1989). Positron tomography demonstrates frontal lobe hypometabolism in PSP. Ann. Neurol., 25, 131–9CrossRef Google Scholar

Golbe, L. I.The epidemiology of PSP (1996). Adv. Neurol., 69, 25–31Google Scholar

Golbe, L. I. & Dickson, D. W. (1995). Familial autopsy-proven PSP. Neurology, 45 (Suppl 4), A255Google Scholar

Golbe, L. I., Davis, P. H., Schoenberg, B. S. & Duvoisin, R. C. (1988). Prevalence and natural history of PSP. Neurology, 38, 1031–4CrossRef Google Scholar

Golbe, L. I., Davis, P. H. & Lepore, F. E. (1989). Eyelid movement abnormalities in PSP. Mov. Disord., 4, 297–302CrossRef Google Scholar

Golbe, L. I., Rubin, R. S., Cody, R. P.et al. (1996). Follow-up study of risk factors in PSP. Neurology, 47, 148–54CrossRef Google Scholar

Golbe, L. I. and the Medical Advisory Board of the Society for PSP (1997). A clinical rating scale and staging system for PSP. Neurology, 48 (suppl), A326Google Scholar

Golbe, L. I., Lepore, F. E., Johnson, W. G., Belsh, J. M., Powell, A. L. & Treiman, D. M. (1999). Inter-rater reliability of the PSP rating scale. Neurology, 52 (suppl), A227Google Scholar

Golbe, L. I., Lazzarini, A. M., Spychala, J. R.et al. (2001). The tau A0 allele in Parkinson's disease. Mov. Disord., 16, 442–7CrossRef Google Scholar PubMed

Habert, M. O., Spampinato, U., Mas, J. L.et al. (1991). A comparative technetium 99m hexamethylpropylene amine oxime SPECT study in different types of dementia. Eur. J. Nucl. Med., 18, 3–11CrossRef Google Scholar

Halliday, G. M., Hardman, C. D., Cordato, N. J., Hely, M. A. & Morris, J. G. (2000). A role for the substantia nigra pars reticulata in the gaze palsy of PSP. Brain, 123, 724–32CrossRef Google Scholar

Hardman, C. D. & Halliday, G. M. (1999). The external globus pallidus in patients with PD and PSP. Mov. Disord., 14, 626–333.0.CO;2-U>CrossRef Google Scholar

Hauw, J.-J., Verny, M., Delaere, P., Cervera, P., He, U. & Duyckaerts, C. (1990). Constant neurofibrillary changes in the neocortex in PSP. Basic differences with Alzheimer's disease and aging. Neurosci. Lett., 119, 182–6CrossRef Google Scholar PubMed

Hauw, J.-J., Daniel, S. E., Dickson, D.et al. (1994). Preliminary NINDS neuropathologic criteria for Steele–Richardson–Olszewski syndrome (PSP). Neurology, 44, 2015–19CrossRef Google Scholar

Henderson, J. M., Carpenter, K., Cartwright, H. & Halliday, G. M. (2000). Loss of thalamic intralaminar nuclei in PSP and PD: clinical and therapeutic implications. Brain, 123, 1410–21CrossRef Google Scholar

Higgins, J. J., Adler, R. L. & Loveless, J. M. (1999). Mutational analysis of the tau gene in PSP.Neurology, 53, 1421–4CrossRef Google Scholar

Hoehn, M. M. & Yahr, M. D. (1967). Parkinsonism: onset, progression, and mortality. Neurology, 17, 427–42CrossRef Google Scholar

Hof, P. R., Delacourte, A. & Bouras, C. (1992). Distribution of cortical neurofibrillary tangles in PSP: a quantitative analysis of six cases. Acta Neuropathol. (Berl.), 84, 45–51CrossRef Google Scholar

Houlden, H., Baker, M., Morris, H. R.et al. (2001). Corticobasal degeneration and PSP share a common tau haplotype. Neurology, 56, 1702–6CrossRef Google Scholar

Hutton, M., Lendon, C. L., Rizzu, P.et al. (1998). Association of missense and 5′-splice-site mutation in tau with the inherited dementia FTDP-17. Nature, 393, 702–5CrossRef Google Scholar PubMed

Ikeda, K., Akiyama, H., Haga, C., Kondo, H., Arima, K. & Oda, T. (1994). Argyrophilic thread-like structure in corticobasal degeneration and supranuclear palsy. Neurosci. Lett., 174, 157–9CrossRef Google Scholar PubMed

Ilgin, N., Zubieta, J., Reich, S. G., Dannals, R. F., Ravert, H. T. & Frost, J. J. (1999). PET imaging of the dopamine transporter in PSP and PD. Neurology, 52, 1221–6CrossRef Google Scholar

Imai, H., Nakamura, T., Kondo, T. & Narabayashi, H. (1993). Dopa-unresponsive pure akinesia or freezing: a condition with a wide spectrum of PSP?Adv. Neurol., 60, 622–5Google Scholar PubMed

Inagaki, T., Ishino, H., Seno, H., Yamamori, C. & Iijima, M. (1994). An autopsy case of PSP with astrocytic inclusions. Jap. J. Psychiatry Neurol., 48, 85–9Google Scholar PubMed

Ishizawa, K. & Dickson, D. W. (2001). Microglial activation parallels system degeneration in PSP and corticobasal degeneration. J. Neuropathol. Exp. Neurol., 60, 647–57CrossRef Google Scholar PubMed

Iwatsubo, T., Hasegawa, M. & Ihara, Y. (1994). Neuronal and glial tau-positive inclusions in diverse neurologic diseases share common phosphorylation characteristics. Acta Neuropathol. (Berl.), 88, 129–36CrossRef Google Scholar PubMed

Jackson, J. A., Jankovic, J. & Ford, J. (1983). PSP: Clinical features and response to treatment in 16 patients. Ann. Neurol., 13, 273–8CrossRef Google Scholar PubMed

Jankovic, J. (1983). Controlled trial of pergolide mesylate in Parkinson's disease and PSP. Neurology, 33, 505–7CrossRef Google Scholar

Jankovic, J. (1984a). Apraxia of eyelid opening in PSP: Reply. Neurology, 15, 116Google Scholar

Jankovic, J. (1984b). PSP: Clinical and pharmacologic update. Neurol. Clin., 2, 473–86Google Scholar

Jankovic, J., Beach, J., Schwartz, K. & Contant, C. (1995). Tremor and longevity in relatives of patients with Parkinson's disease, essential tremor, and control subjects. Neurology, 45, 645–8CrossRef Google Scholar PubMed

Jankovic, J. & Friedman, D. I., Pirozzolo, F. J. & McCrary, J. A. (1990). PSP: motor, neurobehavioral, and neuro-ophthalmic findings. Adv. Neurol., 53, 293–304Google Scholar

Jankovic, J. & Van der Linden, C. (1990). PSP (Steele–Richardson–Olszewski syndrome). In Movement Disorders, ed. S. Chokroverty, pp. 267–86. New York: PMA Publishing

Jellinger, K. (1988). The pedunculopontine nucleus in Parkinson's disease, PSP and Alzheimer's disease. J. Neurol. Neurosurg. Psychiatr., 52, 540–3CrossRef Google Scholar

Jellinger, K. A. & Bancher, C. (1992). Neuropathology. In PSP: Clinical and Research Approaches, ed. I. Litvan & Y. Agid, pp. 44–88. New York: Oxford

Jendroska, K., Hoffmann, O., Schelosky, L., Lees, A. J., Poewe, W. & Daniel, S. (1994). Absence of disease related prion protein in neurodegenerative disorders presenting with Parkinson's syndrome. J. Neurol. Neurosurg. Psychiatr., 57, 1249–51CrossRef Google Scholar PubMed

Johnston, B. T., Castell, J. A., Stumacher, S.et al. (1997). Comparison of swallowing function in PD and PSP. Mov. Disord., 12, 322–7CrossRef Google Scholar

Josephs, K. A., Gerpen, M. W. & Gerpen, J. A. (2003). Adult onset Niemann–Pick disease type C presenting with psychosis. J. Neurol. Neurosurg. Psychiatr., 74, 528–9CrossRef Google Scholar PubMed

Juncos, J. L., Hirsch, E. C., Malessa, S., Duyckaerts, C., Hersh, L. B. & Agid, Y. (1991). Mesencephalic cholinergic nuclei in PSP. Neurology, 41, 25–30CrossRef Google Scholar

Kertzman, C., Robinson, D. L. & Litvan, I. (1990). Effects of physostigmine on spatial attention in patents with PSP. Arch. Neurol., 47, 1346–50CrossRef Google Scholar

Kida, E., Barcikowska, M. & Niemszewska, M. (1992). Immunohistochemical study of a case with PSP without ophthalmoplegia. Acta Neuropathol., 83, 328–32CrossRef Google Scholar PubMed

Kim, S. Y., Jeiter, T. M. & Steinert, P. M. (2002). Transglutaminases in disease. Neurochem. Internat., 40, 85–103CrossRef Google Scholar

Kimber, J., Mathias, C. J., Lees, A. J.et al. (2000). Physiological, pharmacological and neurohormonal assessment of autonomic function in PSP. Brain, 123, 1422–30CrossRef Google Scholar

Kluin, K. J., Foster, N. L., Berent, S. & Gilman, S. (1993). Perceptual analysis of speech disorders in PSP. Neurology, 43, 563–6CrossRef Google Scholar

Koller, W. C., Morantz, R., Vetere-Overfield, B. & Waxman, M. (1989). Autologous adrenal medullary transplant in PSP. Neurology, 39, 1066–8CrossRef Google Scholar

Kompoliti, K., Goetz, C. G., Litvan, I., Jellinger, K. & Verny, M. (1998). Pharmacological therapy in PSP. Arch. Neurol., 55, 1099–102CrossRef Google Scholar

Kurtzke, J. F. & Kurland, L. T. (1973). Neuroepidemiology: a summation. In Epidemiology of Neurologic and Sense Organ Disorders, ed. L. T. Kurland, J. F. Kurtzke & I. D. Goldberg, pp. 305–332. Cambridge, MA: HarvardCrossRef

Landwehrmeyer, B. & Palacios, J. M. (1994). Neurotransmitter receptors in PSP. J. Neural. Trans.. suppl 42, 229–46Google Scholar

Lannuzel, A., Michel, P. P., Caparros-Lefebvre, D., Abaul, J., Hocquemiller, R. & Ruberg, M. (2001). Toxicity of Annonaceae for dopaminergic neurons: potential role in atypical parkinsonism in Guadeloupe. Mov. Disord., 17, 84–90CrossRef Google Scholar

Leenders, K. L., Frackowiak, R. S. J. & Lees, A. J. (1988). Steele–Richardson–Olszewski syndrome: brain energy metabolism, blood flow and fluorodopa uptake measured by positron emission tomography. Brain, 111, 615–30CrossRef Google Scholar PubMed

Leigh, R. J. & Riley, D. E. (2000). Eye movements in parkinsonism: it's saccadic speed that counts. Neurology, 54, 1018–19CrossRef Google Scholar PubMed

Lennox, G., Lowe, J., Morrell, K., Landon, M. & Mayer, R. J. (1988). Ubiquitin is a component of neurofibrillary tangles in a variety of neurodegenerative diseases. Neurosci. Lett., 94, 211–17CrossRef Google Scholar

Leopold, N. A. & Kagel, M. C. (1997). Dysphagia in PSP: radiologic features. Dysphagia, 12, 140–3CrossRef Google Scholar PubMed

Lepore, F. E. & Duvoisin, R. C. (1985). “Apraxia” of eyelid opening: an involuntary levator inhibition. Neurology, 35, 423–7CrossRef Google Scholar

Levy, R., Ruberg, M., Herrero, M. T.et al. (1995). Alterations of GABAergic neurons in the basal ganglia of patients with PSP: an in situ hybridization study of GAD67 messenger RNA. Neurology, 45, 127–34CrossRef Google Scholar

Lewis, J., McGowan, E., Rockwood, J.et al. (2000). Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nat. Genet., 25, 402–5CrossRef Google Scholar PubMed

Lewis, J., Dickson, D. W., Lin, W.-, L.et al. (2001). Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science, 293, 1487–91CrossRef Google Scholar PubMed

Leygonie, F., Thomas, J., Degos, J. D., Bouchareine, A. & Barbizet, J. (1976). Troubles du sommeil dans la maladie de Steele–Richardson: etude polygraphique de 3 cas. Rev. Neurol., 132, 125–36Google Scholar

Litvan, I., Gomez, C., Atack, J. R.et al. (1989). Physostigmine treatment of PSP. Ann. Neurol., 26, 404–7CrossRef Google Scholar

Litvan, I., Blesa, R., Clark, K.et al. (1994). Pharmacological evaluation of the cholinergic system in PSP. Ann. Neurol., 36, 55–61CrossRef Google Scholar

Litvan, I., Agid, Y., Calne, D.et al. (1996a). Clinical research criteria for the diagnosis of PSP: report of the NINDS-SPSP International Workshop. Neurology, 47, 1–9CrossRef Google Scholar

Litvan, I., Mega, M. S., Cummings, J. L. & Fairbanks, L. (1996b). Neuropsychiatric aspects of PSP. Neurology, 47, 1184–9CrossRef Google Scholar

Litvan, I., Campbell, G., Mangone, C. A.et al. (1997a). Which clinical features differentiate PSP from related disorders? A clinicopathological study. Brain, 120, 65–74CrossRef Google Scholar

Litvan, I., Sastry, N. & Sonies, B. C. (1997b). Characterizing swallowing abnormalities in PSP. Neurology, 48, 1654–62CrossRef Google Scholar

Litvan, I., Baker, M. & Hutton, M. (2001a). Tau genotype: no effect on onset, symptom severity, or survival in PSP. Neurology, 57, 138–40CrossRef Google Scholar

Litvan, I., Phipps, M., Pharr, V. L., Hallett, M., Grafman, J. & Salazar, A. (2001b). Randomized placebo-controlled trial of donepezil in patients with PSP. Neurology, 57, 467–73CrossRef Google Scholar

Liu, W. K., Le, T. V., Adamson, J.et al. (2001). Relationship of the extended tau haplotype to tau biochemistry and neuropathology in PSP. Ann. Neurol., 50, 494–502CrossRef Google Scholar

Love, S., Saitoh, T., Quijada, S., Cole, G. M. & Terry, R. D. (1988). Alz-50, ubiquitin and tau immunoreactivity of neurofibrillary tangles, Pick bodies and Lewy bodies. J. Neuropathol. Exp. Neurol., 47, 393–405CrossRef Google Scholar PubMed

Maher, E. R. & Lees, A. J. (1986). The clinical features and natural history of the Steele–Richardson–Olszewski syndrome (PSP). Neurology, 36, 1005–8CrossRef Google Scholar

Malessa, S., Gaymard, B., Rivaud, S.et al. (1994). Role of pontine nuclei damage in smooth pursuit impairment of PSP: a clinical–pathologic study. Neurology, 44, 716–21CrossRef Google Scholar PubMed

Masdeu, J. C., Alampur, U., Cavaliere, R. & Tavoulareas, G. (1994). Astasia and gait failure with damage of the pontomesencephalic locomotor region. Ann. Neurol., 35, 619–21CrossRef Google Scholar PubMed

Mastaglia, F. L., Grainger, K., Kee, F., Sadka, M. & Lefroy, R. (1973). PSP (the Steele–Richardson–Olszewski syndrome): clinical and electrophysiological observations in eleven cases. Proc. Austral. Assoc. Neurol., 10, 35–44Google Scholar

Masucci, E. F. & Kurtzke, J. F. (1989). Tremor in PSP. Acta Neurol. Scand., 80, 296–300CrossRef Google Scholar

Matsuo, H., Takashima, H., Kishikawa, M.et al. (1991). Pure akinesia: an atypical manifestation of PSP. J. Neurol. Neurosurg. Psychiatr., 54, 397CrossRef Google Scholar

Milberg, W. & Albert, M. (1989). Cognitive differences between patients with PSP and Alzheimer's disease. J. Clin. Exp. Neuropsychol., 11, 605–11CrossRef Google Scholar PubMed

Mizusawa, H., Mochizuki, A., Ohkoshi, N., Yoshizawa, K., Kanazawa, I. & Imai, H. (1993). PSP presenting with pure akinesia. Adv. Neurol., 60, 618–21Google Scholar

Molinuevo, J. L., Valldeoriola, F., Alegret, M., Oliva, R. & Tolosa, E. (2000). PSP: earlier age of onset in patients with the tau protein A0/A0 genotype. J. Neurol., 247, 206–8CrossRef Google Scholar PubMed

Montpetit, V., Clapin, D. R. & Guberman, A. (1985). Substructure of 20 nm filaments of PSP. Acta Neuropathol., 68, 311–18CrossRef Google Scholar

Mori, H., Nishimura, M., Namba, Y. & Oda, M. (1994). Corticobasal degeneration: a disease with widespread appearance of abnormal tau and neurofibrillary tangles, and its relation to PSP. Acta Neuropathol., 88, 113–21CrossRef Google Scholar

Moriizumi, T. & Hattori, T. (1992). Separate neuronal populations of the rat globus pallidus projecting to the subthalamic nucleus, auditory cortex and pedunculopontine tegmental area. Neuroscience, 46, 701–10CrossRef Google Scholar PubMed

Morris, H. R., Gibb, G., Katzenschlager, R.et al. (2002). Pathological, clinical and genetic heterogeneity in PSP. Brain, 125, 969–75CrossRef Google Scholar

Morris, H. R., Schrag, A., Nath, U.et al. (2001). Effect of ApoE and tau on age of onset of PSP and multiple system atrophy. Neurosci. Lett., 312, 118–20CrossRef Google Scholar PubMed

Morris, H. R., Vaughan, J. R., Datta, S. R.et al. (2000). Multiple system atrophy / PSP: α-synuclein, synphilin, tau, and APOE. Neurology, 55, 1918–20CrossRef Google Scholar PubMed

Muller, J., Wenning, G. K., Verny, M.et al. (2001). Progression of dysarthria and dysphagia in postmortem-confirmed parkinsonian disorders. Arch. Neurol., 58, 259–64CrossRef Google Scholar PubMed

Nagahama, Y., Fukuyama, H., Turjanski, N.et al. (1997). Cerebral glucose metabolism in corticobasal degeneration: comparison with PSP and normal controls. Mov. Disord., 12, 691–6CrossRef Google Scholar PubMed

Nath, U., Ben-Shlomo, Y., Thomson, R. G.et al. (2001). The prevalence of PSP (Steele–Richardson–Olszewski syndrome) in the UK. Brain, 124, 1438–49CrossRef Google Scholar

Neary, D., Snowdon, J. S., Shields, R. A.et al. (1987). Single photon emission tomography using 99mTc-HM-PAO in the investigation of dementia. J. Neurol. Neurosurg. Psychiatr., 50, 1101–9CrossRef Google Scholar

Nelson, S. J., Yen, S-, H., Davies, P. & Dickson, D. W. (1989). Basal ganglia neuropil threads in PSP. J. Neuropathol. Exp. Neurol., 48, 324CrossRef Google Scholar

Newman, G. C. (1985). Treatment of PSP with tricyclic antidepressants. Neurology, 35, 1189–93CrossRef Google Scholar PubMed

Nieforth, K. A. & Golbe, L. I. (1993). Retrospective study of drug response in 87 patients with PSP. Clin. Neuropharmacol., 16, 338–46CrossRef Google Scholar

Nuwer, M. R. (1981). PSP despite normal eye movements. Arch. Neurol., 38, 784CrossRef Google Scholar

Odetti, P., Garibaldi, S., Norese, R.et al. (2000). Lipoperoxidation is selectively involved in PSP. J. Neuropath. Exp. Neurol., 59, 393–7CrossRef Google Scholar

Ohara, S., Kondo, K., Morita, H., Maruyama, K., Ikeda, S. & Yanagisawa, N. (1992). PSP-like syndrome in two siblings of a consanguineous marriage. Neurology, 42, 1009–14CrossRef Google Scholar

Olszewski, J., Steele, J. & Richardson, J. C. (1963). Pathological report on six cases of heterogeneous system degeneration. J. Neuropathol. Exp. Neurol., 23, 187–8Google Scholar

Oyanaki, K., Takahashi, H., Wakabayashi, K. & Ikuta, F. (1991). Large neurons in the neostriatum in Alzheimer's disease and PSP: a topographic, histologic and ultrastructural investigation. Brain Res., 544, 221–6CrossRef Google Scholar

Pahwa, R., Koller, W. C. & Stern, M. B. (1993). Primary pallidal atrophy, In Parkinsonian Syndromes, ed. M. B. Stern & W. C. Koller, pp. 433–40. New York: Marcel Dekker

Pascual, J., Berciano, J., Gonzalez, A. M., Grijalba, B., Figols, J. & Pazos, A. (1993). Autoradiographic demonstration of loss of alpha-2-adrenoceptors in PSP: preliminary report. J. Neurol. Sci., 114, 165–9CrossRef Google Scholar PubMed

Pastor, P., Ezquerra, M., Tolosa, E.et al. (2001). Further extension of the H1 haplotype associated with PSP. Mov Disord., 17, 550–556CrossRef Google Scholar

Pfaffenbach, D. D., Layton, D. D. & Kearns, T. P. (1972). Ocular manifestations in PSP. Am. J. Ophthalmol., 74, 1179–84CrossRef Google Scholar

Piccini, P., Yebenes, J., Lees, A. J.et al. (2001). Familial PSP: detection of subclinical cases using 18F-dopa and 18-fluorodeoxyglucose positron emission tomography. Arch. Neurol., 58, 1846–51CrossRef Google Scholar

Piccione, F., Mancini, E., Tonin, P. & Bizzarini, M. (1997). Botulinum toxin treatment of apraxia of eyelid opening in PSP: report of two cases. Arch. Phys. Med. Rehab., 78, 525–9CrossRef Google Scholar PubMed

Pillon, B., Deweer, B., Michon, A., Malapani, C., Agid, Y. & Dubois, B. (1994). Are explicit memory disorders of PSP related to damage to striatofrontal circuits? Comparison with Alzheimer's, Parkinson's and Huntington's diseases. Neurology, 44, 1264–70CrossRef Google Scholar PubMed

Pillon, B. & Dubois, B. (1992). Cognitive and behavioral impairments. In PSP: Clinical and Research Approaches, ed. I. Litvan, and Y. Agid, pp. 223–39. New York: Oxford

Pillon, B., Gouider-Khouja, N., Deweer, B.et al. (1995). Neuropsychological pattern of striatonigral degeneration: comparison with Parkinson's disease and PSP. J. Neurol. Neurosurg. Psychiatr., 58, 174–9CrossRef Google Scholar

Podoll, K., Schwarz, M. & Noth, J. (1991). Language functions in PSP. Brain, 114, 1457–72CrossRef Google Scholar

Pollock, N. J., Mirra, S. S., Binder, L. I., Hansen, L. A. & Wood, J. G. (1986). Filamentous aggregates in Pick's disease, PSP, and Alzheimer's disease share antigenic determinants with microtubule-associated protein, tau. Lancet, ii, 1211CrossRef Google Scholar

Polo, K. B. & Jabbari, B. (1994). Botulinum toxin-A improves the rigidity of progressive supranculear palsy. Ann. Neurol., 35, 237–9CrossRef Google Scholar PubMed

Powell, H. C., London, G. W. & Lampert, P. W. (1974). Neurofibrillary tangles in PSP. J. Neuropath. Exp. Neurol., 33, 98–106CrossRef Google Scholar

Probst, A., Langui, D., Lautenschlager, C., Jlrich, J., Brion, J. P. & Anderton, B. H. (1988). PSP: extensive neuropil threads in addition to neurofibrillary tangles. Acta Neuropathol. (Berl.), 77, 61–8CrossRef Google Scholar PubMed

Probst, A., Luginbühl, M., Langui, D., Ulrich, J. & Landwehrmeyer, B. (1994). Pathology of the striatum in PSP: abnormal tau proteins in astrocytes and cholinergic interneurons. Neurodegeneration, 2, 183–93Google Scholar

Rafal, R. D. & Grimm, R. J. (1981). PSP: Functional analysis of the response to methysergide and antiparkinsonian agents. Neurology, 31, 1507–18CrossRef Google Scholar

Rafal, R. D., Posner, M. I., Friedman, J. H., Inhoff, A. W. & Bernstein, E. (1988). Orienting of visual attention in PSP. Brain, 111, 267–80CrossRef Google Scholar

Rajput, A. H., Offord, K. P., Beard, C. M. & Kurland, L. T. (1984). Epidemiology of parkinsonism: incidence, classification, and mortality. Ann. Neurol., 16, 278–82CrossRef Google Scholar

Rascol, O., Sabatini, U., Simonetta-Moreau, M., Montastruc, J. L., Rascol, A. & Clanet, M. (1991). Square wave jerks in parkinsonian syndromes. J. Neurol. Neurosurg. Psychiatr., 54, 599–602CrossRef Google Scholar PubMed

Rascol, O., Clanet, M., Senard, J. M., Montastruc, J. L. & Rascol, A. (1993). Vestibulo-ocular reflex in Parkinson's disease and multiple system atrophy. Adv. Neurol., 60, 395–7Google Scholar PubMed

Richardson, J. C., Steele, J. & Olszewski, J. (1963). Supranuclear ophthalmoplegia, pseudobulbar palsy, nuchal dystonia and dementia: a clinical report on eight cases of “heterogeneous system degeneration.”Trans. Am. Neurol. Assoc., 88, 25–9Google Scholar

Riley, D. E., Fogt, N. & Leigh, R. J. (1994). The syndrome of “pure akinesia” and its relationship to PSP. Neurology, 44, 1025–9CrossRef Google Scholar

Rivest, J., Quinn, N. & Marsden, C. D. (1990). Dystonia in Parkinson's disease, multiple system atrophy, and PSP. Neurology, 40, 1571–8CrossRef Google Scholar

Robbins, T. W., James, M., Owen, A. M.et al. (1994). Cognitive deficits in PSP, Parkinson's disease, and multiple system atrophy in tests sensitive to frontal lobe dysfunction. J. Neurol. Neurosurg. Psychiatr., 57, 79–88CrossRef Google Scholar

Rojo, A., Pernaute, S., Fontán, A.et al. (1999). Clinical genetics of familial PSP. Brain, 122, 1233–45CrossRef Google Scholar

Rosser, A. & Hodges, J. R. (1994). Initial letter and semantic category fluency in Alzheimer's disease, Huntington's disease, and PSP. J. Neurol. Neurosurg. Psychiatr., 57, 1389–94CrossRef Google Scholar

Rub, U., Del Tredici, K., Schultz, C.et al. (2002). PSP: neuronal and glial cytoskeletal pathology in the higher order processing autonomic nuclei of the lower brainstem. Neuropathol. Appl. Neurobiol., 28, 12–22CrossRef Google Scholar PubMed

Ruberg, M., Javoy-Agid, F., Hirsch, E.et al. (1985). Dopaminergic and cholinergic lesions in PSP. Ann. Neurol., 18, 523–9CrossRef Google Scholar

Saitoh, H., Yoshii, F. & Shinohara, Y. (1987). Computed tomographic findings in PSP. Neuroradiology, 29, 168–71CrossRef Google Scholar

Sakakibara, R., Hattori, T., Tojo, M., Yamanishi, T. & Yasuda, K. (1993). Micturitional disturbance in PSP. J. Auton. Nerv. Syst., 45, 101–6CrossRef Google Scholar

Savoiardo, M., Strada, L., Girotti, F.et al. (1989). MR imaging in PSP and Shy–Drager syndrome. J. Comput. Assist. Tomogr., 13, 555–60CrossRef Google Scholar PubMed

Scaravilli, T., Pramstaller, P. P., Salerno, A.et al. (2000). Neuronal loss in Onuf's nucleus in three patients with progressive supranuclear palsy. Ann. Neurol., 48, 97–1013.0.CO;2-Z>CrossRef Google Scholar PubMed

Schneider, J. A., Gearing, M., Robbins, R. S., l'Aune, W. & Mirra, S. S. (1995). Apolipoprotein E genotype in diverse neurodegenerative disorders. Ann. Neurol., 38, 131–5CrossRef Google Scholar PubMed

Schonfeld, S. M., Golbe, L. I., Safer, J., Sage, J. I. & Duvoisin, R. C. (1987). Computed tomographic findings in PSP: correlation with clinical grade. Mov. Disord., 2, 263–78CrossRef Google Scholar PubMed

Schrag, A., Ben-Shlomo, Y. & Quinn, N. (1999). Prevalence of PSP and MSA: a cross-sectional study. Lancet, 354, 1771–2CrossRef Google Scholar PubMed

Schwarz, J., Tatsch, K., Arnold, G.et al. (1992). 123-Iodobenzamide-SPECT predicts dopaminergic responsiveness in patients with de novo parkinsonism. Neurology, 42, 556–61CrossRef Google Scholar

Seppi, K., Schocke, M. F., Esterhammer, R.et al. (2003). Diffusion-weighted imaging discriminates PSP from PD, but not from the Parkinson variant of multiple system atrophy. Neurology, 60, 922–7CrossRef Google Scholar

Shinotoh, H., Namba, H., Yamaguchi, M.et al. (1999). PET measurement of acetylcholinesterase activity reveals differential loss of ascending cholinergic systems in PD and PSP. Ann. Neurol., 46, 62–93.0.CO;2-P>CrossRef Google Scholar

Sonies, B. C. (1992). Swallowing and speech disturbances. In PSP: Clinical and Research Approaches, ed. I. Litvan & Y. Agid, pp. 240–54. New York: Oxford

Sosner, J., Wall, G. C. & Sznajder, J. (1993). PSP: clinical presentation and rehabilitation of two patients. Arch. Phys. Med. Rehab., 74, 537–9CrossRef Google Scholar PubMed

Spillantini, M. G., Murrell, J. R., Goedert, M., Farlow, M. R., Klug, A. & Ghetti, B. (1988). Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc. Natl Acad. Sci., USA, 95, 7737–41CrossRef Google Scholar

Stanford, P. M., Halliday, G. M., Brooks, W. S.et al. (2000). PSP pathology caused by a novel silent mutation in exon 10 of the tau gene: expansion of the disease phenotype caused by tau gene mutations. Brain, 123, 880–93CrossRef Google Scholar

Steele, J. C., Richardson, J. C. & Olszewski, J. (1964). PSP: A heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum, with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch. Neurol., 10, 333–59CrossRef Google Scholar

Steele, J. C., Caparros-Lefebvre, D., Lees, A. J. & Sacks, O. W. (2002). PSP and its relation to Pacific foci of the parkinson-dementia complex and Guadeloupean parkinsonism. Parkinsonism Rel. Dis., 9, 39–54CrossRef Google Scholar

Stern, M. B., Braffman, B. H., Skolnick, B. E., Hurtig, H. I. & Grossman, R. I. (1989). Magnetic resonance imaging in Parkinson's disease and parkinsonian syndromes. Neurology, 39, 1524–6CrossRef Google Scholar

Swerdlow, R. H., Golbe, L. I., Parks, J. K.et al. (2000). Mitochondrial dysfunction in cybrid lines expressing mitochondrial genes from patients with PSP. J. Neurochem., 75, 1681–4CrossRef Google Scholar

Tabaton, M., Whitehouse, P. J., Perry, G., Davies, P., Autilio-Gambetti, L. & Gambetti, P. (1988). Alz 50 recognized abnormal filaments in Alzheimer's disease and PSP. Ann. Neurol., 24, 407–13CrossRef Google Scholar

Tabaton, M., Rolleri, M., Masturzo, P.et al. (1995). Apolipoprotein E epsilon 4 allele frequency is not increased in PSP. Neurology, 45, 1764–5CrossRef Google Scholar PubMed

Tagliavini, F., Pilleri, G., Bouras, C. & Constantinidis, J. (1984). The basal nucleus of Meynert in patients with PSP. Neurosci. Lett., 44, 37–42CrossRef Google Scholar

Tanner, C. M., Goetz, C. G. & Klawans, H. L. (1987). Multi-infarct PSP. Neurology, 37, 1819CrossRef Google Scholar

Tellez-Nagel, I. & Wisniewski, H. M. (1973). Ultrastructure of neurofibrillary tangles in Steele-Richardson-Olszewski syndrome. Arch. Neurol., 29, 324–7CrossRef Google Scholar PubMed

Testa, D., Monza, D., Ferrarini, M., Soliveri, P., Girotti, F. & Filippini, G. (2001). Comparison of natural histories of PSP and multiple system atrophy. Neurol. Sci., 22, 247–51CrossRef Google Scholar PubMed

Tetrud, J. W., Golbe, L. I., Farmer, P. M. & Forno, L. S. (1996). Autopsy-proven PSP in two siblings. Neurology, 46, 931–4CrossRef Google Scholar PubMed

Timmons, J. H., Bonikowski, F. W. & Harshorne, M. F. (1989). Iodoamphetamine-123 brain imaging demonstrating cortical deactivation in a patient with PSP. Clin. Nucl. Med., 14, 841–2CrossRef Google Scholar

Togo, T. & Dickson, D. W. (2002). Tau accumulation in astrocytes in PSP is a degenerative rather than a reactive process. Acta Neuropathol., 104, 398–402Google Scholar PubMed

Tolosa, E. S. & Zeese, J. A. (1979). Brainstem auditory evoked responses in PSP. Ann. Neurol., 6, 369CrossRef Google Scholar

Tomonaga, M. (1977). Ultrastructure of neurofibrillary tangles in PSP. Acta Neuropathol. (Berl.), 37, 1771–1781CrossRef Google Scholar

Troost, B. T. & Daroff, R. B. (1977). The ocular motor defects in PSP. Ann. Neurol., 2, 397–403CrossRef Google Scholar

Truong, D. D., Harding, A. E., Scaravilli, F., Smith, S. J. M., Morgan-Hughes, J. A. & Marsden, C. D. (1990). Movement disorders in mitochondrial myopathies: a study of nine cases with two autopsy studies. Mov. Disord., 5, 109–17CrossRef Google Scholar PubMed

Uitti, R., Evidente, V. G. H., Dickson, D. W. & Graff-Radford, N. (1999). A kindred with familial PSP. Neurology, 52, A227Google Scholar

Valls-Solé, J., Valldeoriola, F., Tolosa, E. & Marti, M. J. (1997). Distinctive abnormalities of facial reflexes in patients with PSP. Brain, 120, 1877–83CrossRef Google Scholar

Royen, E., Verhoeff, N. F., Speelman, J. D., Wolters, E. C., Kuiper, M. A. & Janssen, A. G. (1993). Multiple system atrophy and PSP: diminished striatal D2 dopamine receptor activity demonstrated by 123I-IBZM single photon emission computed tomography. Arch. Neurol., 50, 513–16CrossRef Google Scholar

Vanacore, N., Bonifati, V., Fabbrini, G.et al. (2000). Smoking habits in multiple system atrophy and PSP. Neurology, 54, 114–19CrossRef Google Scholar

Vermersch, P., Robitaille, Y., Bernier, L., Wattez, A., Gauvreau, D. & Delacourte, A. (1994). Biochemical mapping of neurofibrillary degeneration in a case of PSP: evidence for general cortical involvement. Acta Neuropathol., 87, 572–7CrossRef Google Scholar

Verny, M., Duyckaerts, C., Delaére, P., He, Y. & Hauw, J.-J. (1994). Cortical tangles in PSP. J. Neural. Transm., suppl 42, 179–88CrossRef Google Scholar

Vidailhet, M., Rothwell, J. C., Thompson, P. D., Lees, A. J. & Marsden, C. D. (1992). The auditory startle response in the Steele–Richardson–Olszewski syndrome and Parkinson's disease. Brain, 115, 1181–92CrossRef Google Scholar PubMed

Villares, J., Strada, O., Faucheux, B., Javoy-Agid, F., Agid, Y. & Hirsch, E. C. (1994). Loss of striatal high affinity NGF binding sites in PSP but not in Parkinson's disease. Neurosci. Lett., 182, 59–62CrossRef Google Scholar PubMed

Vitaliani, R., Scaravilli, T., Egarter-Vigl, E.et al. (2002). The pathology of the spinal cord in PSP. J. Neuropathol. Appl. Neurol., 61, 268–74CrossRef Google Scholar

Vodusek, D. B. (2001). Sphincter EMG and differential diagnosis of multiple system atrophy. Mov. Disord., 16, 600–7CrossRef Google Scholar PubMed

Wakabayashi, K., Oyanagi, K., Makifuchi, T.et al. (1994). Corticobasal degeneration: etiopathological significance of the cytoskeletal alterations. Acta Neuropathol., 87, 545–53CrossRef Google Scholar PubMed

Weiner, W. J., Minagar, A. & Shulman, L. M. (1999). Pramipexole in PSP. Neurology, 52, 873–4CrossRef Google Scholar

Wenning, G. K., Ebersbach, G., Verny, M.et al. (1999). Progression of falls in postmortem-confirmed parkinsonian disorders. Mov. Disord., 14, 947–503.0.CO;2-O>CrossRef Google Scholar PubMed

Will, R. G., Lees, A. J., Gibb, W. & Barnard, R. O. (1988). A case of progressive subcortical gliosis presenting clinically as Steele–Richardson–Olszewski syndrome. J. Neurol. Neurosurg. Psychiatr., 51, 1224–7CrossRef Google Scholar PubMed

Winikates, J. & Jankovic, J. (1994). Vascular PSP. J. Neural. Transm., 42 (suppl), 189–201CrossRef Google Scholar

Wittmann, C. W., Wszolek, M. F., Shulman, J. M.et al. (2001). Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles. Science, 293, 711–14CrossRef Google Scholar PubMed

Yamada, T., Calne, D. B., Akiyama, H., McGeer, E. G. & McGeer, P. L. (1993). Further observations on Tau-positive glia in the brains with PSP. Acta Neuropathol., 85, 308–15CrossRef Google Scholar

Young, A. B. (1985). PSP: postmortem chemical analysis. Neurology, 18, 521–2Google Scholar

Yuki, N., Sato, S., Yuasa, T., Ito, J. & Miyatake, T. (1990). Computed tomographic findings of PSP compared with Parkinson's disease. Jpn. J. Med., 29, 506–11CrossRef Google Scholar PubMed

Zweig, R. M., Whitehouse, P. J., Casanova, M. F.et al. (1987). Loss of pedunculopontine neurons in PSP. Ann. Neurol., 22, 18–25CrossRef Google Scholar